C–D | E–H | I–N | O–P | Q–U. Accelerated assessment The accelerated assessment procedure reduces the timeframe for the European Medicines Agency's (EMA) Committee for...
A–B | E–H | I–N | O–P | Q–U. CE marking The CE (Conformité Européene—meaning European Conformity) mark is a mandatory conformity marking for certain products sold within...
A–B | C–D | I–N | O–P | Q–U. Early access to medicines scheme The early access to medicines scheme (EAMS) was launched by the Medicines and Healthcare products Regulatory...
A–B | C–D | E–H | O–P | Q–U. Immunological medicinal product Article 1(4) of Directive 2001/83/EC (consolidated version 26.07.2019), the Pharmaceutical Code defines...
A–B | C–D | E–H | I–N | Q–U. Officinal formula There are exceptions to the requirement that medicinal products must have obtained a marketing authorisation (MA) before...
A–B | C–D | E–H | I–N | O–P. QR code The Quick Response (QR) code is a two-dimensional bar code that is used to provide easy access by patients and/or health care...